Search Prime Grants

HT94252510222

Project Grant

Overview

Grant Description
A randomized controlled multisite trial evaluating SAINT for postpartum depression
Awardee
Magnus Medical
Funding Goals
PEER REVIEWED MEDICAL RESEARCH PROGRAM AWARD MECHANISM: CLINICAL TRIAL AWARD - WITH PLANNING PHASE
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Burlingame, California 940103491 United States
Geographic Scope
Single Zip Code
Related Opportunity
DoD Peer Reviewed Medical, Clinical Trial Award (HT942524PRMRPCTA)
Analysis Notes
Amendment Since initial award the End Date has been extended from 10/31/25 to 10/31/29 and the total obligations have increased 1779% from $532,637 to $10,009,862.
Magnus Medical was awarded Project Grant HT94252510222 worth $10,009,862 from Defense Health Agency in May 2025 with work to be completed primarily in Burlingame California United States. The grant has a duration of 4 years 5 months and was awarded through assistance program 12.420 Military Medical Research and Development. The Project Grant was awarded through grant opportunity DoD Peer Reviewed Medical, Clinical Trial Award.

Status
(Ongoing)

Last Modified 9/12/25

Period of Performance
5/1/25
Start Date
10/31/29
End Date
12.0% Complete

Funding Split
$10.0M
Federal Obligation
$0.0
Non-Federal Obligation
$10.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252510222

Subgrant Awards

Disclosed subgrants for HT94252510222

Transaction History

Modifications to HT94252510222

Additional Detail

Award ID FAIN
HT94252510222
SAI Number
None
Award ID URI
None
Awardee Classifications
Small Business
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
GR1DKGELJGP8
Awardee CAGE
9AQ81
Performance District
CA-15
Senators
Dianne Feinstein
Alejandro Padilla
Modified: 9/12/25